Intervention Review

Depot haloperidol decanoate for schizophrenia

  1. Seema N Quraishi2,
  2. Anthony David2,
  3. Marco A Brasil1,*,
  4. Flávio V Alheira3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 25 JAN 1999

Assessed as up-to-date: 24 NOV 1998

DOI: 10.1002/14651858.CD001361


How to Cite

Quraishi SN, David A, Brasil MA, Alheira FV. Depot haloperidol decanoate for schizophrenia. Cochrane Database of Systematic Reviews 1999, Issue 1. Art. No.: CD001361. DOI: 10.1002/14651858.CD001361.

Author Information

  1. 1

    Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

  2. 2

    Institute of Psychiatry, London, UK

  3. 3

    Rio de Janeiro, Brazil

*Marco A Brasil, Federal University of Rio de Janeiro, R. Gustavo Sampaio 816, apt. 401 Leme, Rio de Janeiro, cep 22010.010, Brazil. brasil@uninet.com.br.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 25 JAN 1999

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.